Screening for hepatocellular carcinoma by Egyptian physicians

Table 6 Relation between doctors’ age and knowledge about screening modalities, educational resources and guidelines

	Age (yr)				P value
	< 45		≥45
	n	%	n	%
Most important HCC screening					0.037a
Physical examination	2	2	1	3
Alpha fetoprotein	27	24	9	21
Ultrasound	65	58	32	76
CT	18	16	0	0
2nd most important HCC screening					0.175
Physical examination	2	2	0	0
Alpha fetoprotein	55	49	16	38
Ultrasound	17	15	4	10
CT	36	32	22	52
Angiography	2	2	0	0
3rd most important HCC screening					0.585
Physical examination	3	3	2	5
Alpha fetoprotein	21	19	13	31
Ultrasound	14	12	3	7
CT	55	49	18	43
Angiography	8	7	3	7
Laparoscopy	11	10	3	7
Screening interval for high risk groups					0.212
3 mo	65	58	29	69
6 mo or more	47	42	13	31
HBV treatment reduces HCC incidence					0.014a
Yes	84	75	39	93
No	28	25	3	7
Familiar with guidelines					0.205
Yes	62	55	28	67
No	50	45	14	33
HCV RNA/ALT level are HCC risk factors					0.08
Yes	57	51	28	67
No	55	49	14	33

^aP < 0.05 considered statistically significant. HCC: Hepatocellular carcinoma; HBV: Hepatitis B virus; HCV: Hepatitis C virus; CT: Computer tomography.